WBB Cuts Pluristem Therapeutics (PSTI) from Spec Buy to Hold
Tweet Send to a FriendGet Alerts PSTI Hot Sheet
Price: $3.00 --0%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 5 | New: 6
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 5 | New: 6
Trade PSTI Now!
WBB Securities downgraded Pluristem Therapeutics (NASDAQ: PSTI) from Speculative Buy to Hold Tuesday morning.
The stock is down 2.9 percent to $3.30 at last check.
For an analyst ratings summary and ratings history on Pluristem Therapeutics click here. For more ratings news on Pluristem Therapeutics click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock is down 2.9 percent to $3.30 at last check.
For an analyst ratings summary and ratings history on Pluristem Therapeutics click here. For more ratings news on Pluristem Therapeutics click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Wells Fargo Downgrades Brinker Int'l (EAT) to Market Perform
- William Blair Downgrades CarMax (KMX) to Market Perform
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
